Blog
RSS FeedPosted by Michael Wonder on 19 Nov 2019
Lung cancer and leukaemia treatments to be added to PBS
19 November 2019 - “Game changing” drugs for types of lung cancer and leukaemia will be added to the Pharmaceutical Benefits ...
Posted by Michael Wonder on 19 Nov 2019
AMA sharpens policy to promote reasonable drug prices
18 November 2019 - Arbitration in determining prescription drug prices is a viable mechanism to address the burden of high ...
Posted by Michael Wonder on 19 Nov 2019
Epilepsy sufferer says victims of PHARMAC drug switch should be compensated
19 November 2019 - An epilepsy sufferer who urged others to boycott the Government's change in anti-epileptic drug medication is ...
Posted by Michael Wonder on 19 Nov 2019
Elizabeth Warren says ‘Medicare for All’ rollout process will take 3 years
16 November 2019 — Elizabeth Warren announced Friday that she would expand public health insurance during her first 100 days ...
Posted by Michael Wonder on 19 Nov 2019
Drug cost legislation gets a push from White House
18 November 2019 - The White House is ramping up its push to get a bill through Congress that curbs ...
Posted by Michael Wonder on 19 Nov 2019
European Medicines Agency grants Orchard Therapeutics accelerated assessment of OTL-200 for patients with metachromatic leukodystrophy
18 November 2019 - Orchard Therapeutics today announced that the CHMP of the EMA has granted an accelerated assessment for OTL-200, ...
Posted by Michael Wonder on 18 Nov 2019
Levo Therapeutics receives fast track designation from FDA for intranasal carbetocin for the treatment of Prader-Willi syndrome
18 November 2019 - Levo Therapeutics announced today that the U.S. FDA has granted Fast Track designation for LV-101 (intranasal carbetocin) ...
Posted by Michael Wonder on 18 Nov 2019
Group launches seven-figure ad buy boosting vulnerable Democrats on drug prices
18 November 2019 - A Democratic group is launching $2 million in new digital ads highlighting vulnerable House Democrats’ efforts ...
Posted by Michael Wonder on 18 Nov 2019
Ontario and Quebec provide reimbursement for HIV therapies Pifeltro (doravirine) and Delstrigo (doravirine/lamivudine/tenofovir disoproxil fumarate)
18 November 2019 - For more than 30 years, Merck has been committed to scientific research and discovery in HIV that ...
Posted by Michael Wonder on 18 Nov 2019
The NHS is facing shortages of lifesaving treatments, says internal document
18 November 2019 - Identifies 17 new shortages including drugs for cancer treatment. ...
Posted by Michael Wonder on 18 Nov 2019
Biosimilars make progress in the Canadian market, but stakeholders see more work ahead
18 November 2019 - While much attention over the past few weeks has been on the US biosimilars market, with its ...
Posted by Michael Wonder on 18 Nov 2019
Funding orphan medicinal products beyond price: sustaining an ecosystem
18 November 2019 - Following a similar legislation in the USA, the EU passed a legislation in 1999 to incentivise ...
Posted by Michael Wonder on 18 Nov 2019
To lower costs, Trump to force hospitals to reveal price of care
15 November 2019 - The Trump administration on Friday announced it would begin forcing hospitals to publicly disclose the discounted ...
Posted by Michael Wonder on 18 Nov 2019
Seelos Therapeutics receives FDA fast track designation for intranasal racemic ketamine (SLS-002)
18 November 2019 - Seelos Therapeutics today announced the U.S. FDA has granted fast track designation to its new, investigational intranasal ...
Posted by Michael Wonder on 18 Nov 2019
Nancy Brunning's death: calls for PHARMAC reform
18 November 2019 - There are calls for PHARMAC to be reformed after the death of actress Nancy Brunning. ...
Posted by Michael Wonder on 18 Nov 2019
National MS Society responds to price of new Biogen/Alkermes MS medication Vumerity
13 November 2019 - The FDA recently approved a new medication for relapsing MS, Vumerity, by Biogen and Alkermes. ...